PATENT CLAIM ANALYSIS

Application Number: 15766560
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["544", "001000"]

Abstract:
The present invention provides a compound of the formula (1): wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Y 1 , Y 2 , L, and m are as defined in the description, and a pharmaceutically acceptable salt thereof, which are useful as a vaccine adjuvant.

Claim (Index 2):
The compound or a pharmaceutically acceptable salt thereof according to  claim 1  wherein X is methylene, oxygen atom, or NR 7 , wherein R 7  is hydrogen atom or an alkyl group of 1 to 3 carbon atoms; R 1  and R 2  are independently hydrogen atom or a substituted or unsubstituted alkyl group of 1 to 6 carbon atoms, provided that when the alkyl group is substituted, it is substituted with 1 to 4 substituents independently selected from the group consisting of hydroxy group and halogen atom; R 3  is an alkyl group of 1 to 6 carbon atoms; and R 4  is hydrogen atom, halogen atom, hydroxy group, an alkyl group of 1 to 3 carbon atoms or an alkoxy group of 1 to 3 carbon atoms.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 91.0
- Lexical Diversity: 1.65
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15763982', '15356311', '13416061', '10110381', '15507888']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7848616841990671
- 35 USC 102 Novelty (BERT): 0.5501925490675419
- Combined Prediction Score: 0.7613947706859145
- Mean Citation Score: 307.9729240000001
- Max Citation Score: 405.57785
- Similarity Product: 352.67069877665045

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test